|
CALL
|
$488,000
|
2.4K
|
Q4 2024
Added 51.86%
|
|
|
CALL
|
$4.77 Million
|
280K
|
Q4 2024
Reduced 57.38%
|
|
|
CALL
|
$0
|
759K
|
Q4 2024
Reduced 11.67%
|
|
|
PUT
|
$0
|
1.17M
|
Q4 2024
Reduced 11.67%
|
|
|
CALL
|
$3.05 Million
|
13K
|
Q4 2024
Added 62.5%
|
|
|
PUT
|
$4.58 Million
|
19.5K
|
Q4 2024
Added 62.5%
|
|
|
CALL
|
$5.68 Million
|
12.1K
|
Q2 2024
Reduced 1.79%
|
|
|
PUT
|
$3.19 Million
|
27K
|
Q1 2024
Reduced 49.01%
|
|
|
CALL
|
$1.61 Million
|
201K
|
Q4 2024
Added 11.54%
|
|
|
PUT
|
$6.29 Million
|
782K
|
Q4 2024
Added 11.54%
|
|
|
CALL
|
$0
|
1.16K
|
Q2 2023
Added 99.65%
|
|
|
CALL
|
$1.68 Million
|
53K
|
Q4 2024
New holding
|
|
|
PUT
|
$3.01 Million
|
690K
|
Q4 2024
Added 666.67%
|
|
|
CALL
|
$3.52 Million
|
39K
|
Q3 2024
Reduced 52.63%
|
|
|
PUT
|
$3.25 Million
|
36K
|
Q3 2024
Reduced 52.63%
|
|
Neumora Therapeutics Inc.
|
PUT
|
$0
|
99.8K
|
Q4 2024
New holding
|
|
|
CALL
|
$4.69 Million
|
140K
|
Q4 2024
New holding
|
|
|
CALL
|
$6 Million
|
70K
|
Q4 2024
Reduced 50.0%
|
|
|
PUT
|
$1.44 Million
|
4.2K
|
Q4 2024
Reduced 70.42%
|
|
|
CALL
|
$3.69 Million
|
27K
|
Q4 2024
Reduced 54.62%
|
|
|
PUT
|
$3.69 Million
|
27K
|
Q4 2024
Reduced 54.62%
|
|
|
CALL
|
$1.6 Million
|
25K
|
Q4 2024
New holding
|
|
|
CALL
|
$0
|
21.9K
|
Q3 2024
New holding
|
|
|
CALL
|
$7.34 Million
|
6.86M
|
Q4 2024
Reduced 50.39%
|
|
|
CALL
|
$2.13 Million
|
18K
|
Q1 2024
Reduced 49.01%
|
|